Carisma Therapeutics, Inc.CARMNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank77
5Y CAGR-11.7%
Studio
Year-over-Year Change

Return on equity

5Y CAGR
-11.7%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024216.69%+166.2%
2023-327.45%-940.0%
202238.98%+20021.1%
2021-0.20%-100.1%
2020307.24%-23.7%
2019402.62%+628.3%
2018-76.22%+52.7%
2017-160.97%-3392.3%
20164.89%+102.8%
2015-176.58%-